[Effects and costs of adjuvant chemotherapy for operable lymph node positive breast cancer with HER2/neu overexpression]

MeSH terms

• Antibodies, Monoclonal / economics
• Antibodies, Monoclonal / therapeutic use
• Antibodies, Monoclonal, Humanized
• Antineoplastic Agents / economics
• Antineoplastic Agents / therapeutic use
• Breast Neoplasms / diagnosis*
• Breast Neoplasms / drug therapy
• Breast Neoplasms / genetics*
• Female
• Humans
• Mass Screening
• Receptor, ErbB-2 / genetics*
• Receptor, ErbB-2 / metabolism
• Trastuzumab